Condition: Spinal Muscular Atrophy Type 3 · Duchenne Muscular Dystrophy (DMD) · Sponsor: Columbia University
The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural environments, for extended periods of time, in DMD and SMA.
This description comes directly from the study's public registry record.
Jacqueline Montes, PT, EdD · 212-305-8916 · jm598@cumc.columbia.edu
Cara Kanner, DPT · 516-581-8150 · chy2112@cumc.columbia.edu
Always discuss trial participation with your own doctor first.
| Stanford University | Palo Alto, California, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06839469